Zolpidem Tartrate
酒石酸唑吡坦
Report date: 2026/04/30 20:00:20
NME
Base Information
Drug NameZolpidem Tartrate
Drug Alias Name +[28]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[13]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved DateN/A
Country/Territory +[12]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A
Develop Information
Active CompaniesCosette Pharmaceuticals IncStanford UniversityEms +[5]
Inactive CompaniesUniversity Of California San FranciscoEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentBiolab Sanus Farmaceutica Llc +[18]
Active Indications +[4]
Inactive Indications +[9]